NASDAQ
3.68USD
+0.10 (+2.65%)
We have scored 5 news catalysts on Anbio Biotechnology Class A Ordinary Shares (NNNN) over the past 12 months. Coverage across the window leans mixed (average ticker sentiment +0.00).
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
161.5M
P/E
—
EPS
—
Beta
5.67
52W range
3.09-44.73
Day range
3.53–3.81
Open
3.53
Prev close
3.58
Volume
22.9K
Avg volume
119.8K
Dividend
0.00
IPO
2025-02-19
No scored news tagged NNNN or its network in the window yet.
Show more NNNN articles →Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Anbio Biotechnology Class A Ordinary Shares — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of Anbio Biotechnology Class A Ordinary Shares, taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for NNNN: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
